Neurospire mendapatkan dana segar dari Capital A Partner

CHARLESTON, SC: July 1, 2014 – Capital A Partners has participated in the Series A investment in NeuroSpire, a Durham, NC-based neuroscience technology company. The company has been licensing its neuromarketing software platform to companies in North and South America, Europe, the Middle East and South Africa since its inception in 2010. Its new offering, NEURO+, applies neuroscience combined with gaming to treat children struggling with ADHD. Past clinical research shows neurofeedback to be as effective as pharmaceutical solutions at treating brain-centered conditions.

 NeuroSpire’s NEURO+ offering will be one of the first commercially available applications in neuroscience for clinical treatment of ADHD. The company’s application combines neurofeedback with popular gaming platforms to provide clinicians and parents an alternative to pharmaceutical treatments. Future applications of the technology include improving mental readiness in athletes and military personnel, as well as treating anxiety, depression and addiction. “Applying proven neuroscience technology through gaming to solve one of our society’s most challenging problems in education is core to our excitement about NeuroSpire,” stated David Mendez, General Partner at CAP A.

“Replacing pharmaceutical treatments with a more sustainable and equally effective solution in the treatment of these conditions is literally a game changer,” added Mendez. Jake Stauch, CEO and founder of NeuroSpire, is a former researcher at the Duke University Center for Cognitive Neuroscience. He founded the company in 2010, and was previously awarded grant funding through NC IDEA and the Duke Innovation & Entrepreneurship Initiative, and was awarded prizes from both the ACC Startup Madness and Duke Startup Challenge competitions.

About four years ago, Jake Stauch was in a neuroscience class at Duke, learning about an intriguing experiment. In it, subjects went through an fMRI while being shown photos of Godiva chocolates. A price accompanied the chocolates, and the subjects had to answer yes or no, would they buy this? Some of their neurons lit up like wildfire.

Chances are, if Stauch was strapped into a machine, his brain would've flickered at the idea, too. Stauch, a confirmed whiz who in high school got a perfect 2400 on his SAT while fighting bronchitis, was inspired. It was an innovative technique, reaching inside buyers' skulls to see what they thought before products even hit the shelves. So he started combing through something like 150 peer-reviewed neuroscience articles. A year later, he founded NeuroSpire, a Durham, North Carolina-based business that gives marketing companies everything they need to conduct their own brain scan-based marketing tests.

"Somebody with no training whatsoever could be set up in minutes to run a brain imaging research study," he says. The guesswork of advertising is turned into numbers that purport to help companies get a window into consumers' heads: to see if They'll buy it, or They won't. That might help explain why ad agencies such as McKinney--which counts Samsung and Sherwin-Williams among its clients--have signed up for NeuroSpire, despite that the scientific merits of such services remain murky.

  Also find out more about Indonesia First Neuromarketing Agency - EMC SQUARE ( www.emc-square.com )